Literature DB >> 15276373

Targeting energy metabolism in Huntington's disease.

Francis O Walker1, Lynn A Raymond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276373     DOI: 10.1016/S0140-6736(04)16739-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Couples' attributions for work function changes in prodromal Huntington disease.

Authors:  Nancy R Downing; Janet K Williams; Jane S Paulsen
Journal:  J Genet Couns       Date:  2010-03-23       Impact factor: 2.537

2.  Neuroendocrine Coordination of Mitochondrial Stress Signaling and Proteostasis.

Authors:  Kristen M Berendzen; Jenni Durieux; Li-Wa Shao; Ye Tian; Hyun-Eui Kim; Suzanne Wolff; Ying Liu; Andrew Dillin
Journal:  Cell       Date:  2016-09-08       Impact factor: 41.582

Review 3.  Therapeutic potential of fluoxetine in neurological disorders.

Authors:  Jop P Mostert; Marcus W Koch; Marco Heerings; Dorothea J Heersema; Jacques De Keyser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.

Authors:  Sheng Chen; Frances Fangjia Lu; Philip Seeman; Fang Liu
Journal:  Neurochem Res       Date:  2012-08-28       Impact factor: 3.996

Review 5.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

6.  IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model.

Authors:  Rana Soylu-Kucharz; Ali Khoshnan; Åsa Petersén
Journal:  iScience       Date:  2022-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.